Protocol for Vaccine Injury Management
Summary A recent Yale study highlights immune system dysregulation in Post-Vaccine Syndrome (PVS) patients, characterized by chronic inflammation, B cell abnormalities, exhausted T cells, viral reactivation (EBV), and emerging autoantibodies. Managing PVS requires a multi-pronged approach focusing on reducing inflammation, … Read More